Gynae BT_Lucknow_2018

ICRU bladder point dose representing bladder trigonum dose

Incontinence G≥2 and

133 109 75 47 32 16 4 1 96 80 69 46 29 15 4 0 115 79 62 45 32 13 6 1 86 58 46 39 27 6 4 2

Dose constraint: <65 Gy Up to 9% G≥2 work in progress:

CTC Grade

EMBRACE I cohort 5 centers included

0

258

1

128

Patients with Bladder wall infiltration excluded Patients with Baseline morbidity assessment and at least one Follow Up included

2

48

3

4

4

1

451 patients

Spampinato, Tanderup et al. Work in progress